Join Live Audience: http://TheDrGliddenShow.tv http://DrGlidden.com/erectile-dysfunction http://JoinTeamGlidden.com (855)-347-3696 Patricia knows a man with …
Video Rating: 5 / 5
Los Angeles, California (PRWEB) June 25, 2014
With military veterans at higher risk of experiencing sexual dysfunction than the general male population and in light of the recent scandal facing the U.S. Department of Veterans Affairs about the delayed medical care of our veterans, Boston Medical Group (BMG), the nations largest private mens sexual health clinics, will offer free diagnostic tests from June 30 July 11, announced board-certified urologist Robert Shaw, M.D., principal member of the BMG medical team.
The specialized tests, which usually cost $ 395, are not offered in most doctors offices and are designed to determine the source of the problem. Post Traumatic Stress Disorder (PTSD) often plays a significant role in sexual dysfunction among our veterans. The sexual problems also may stem from a lack of blood flow, neurological damage, concurrent medications or hormonal imbalance. For instance, many veterans suffer from low testosterone levels, which can adversely affect their cardiovascular health and shorten their life expectancy. The condition is often under diagnosed and untreated. Only through a thorough evaluation can a proper diagnosis treatment plan be recommended.
According to the National Center for Biotechnology Information, mens sexual health issues are prevalent among veterans, but patterns of documentation suggest that they may be under-reported or incompletely addressed. In those studies, rates of sexual dysfunction were as high as 80%.
Another study by the Veterans Affairs Pacific Islands Health Care System in Honolulu, looked at rates of sexual dysfunction among 53 male veterans being treated for PTSD and found that more than 90% of them were experiencing some form of sexual dysfunction with 74% having reduced sexual desire, 49% with erectile dysfunction and 15% with some form of ejaculatory problem.
Many of the brave men who served us are not getting the care they need at our VAs, so we hope to reach as many of them as possible with this public service that revolves around Independence Day said Shaw, who has been in practice for more than 40 years. Too many men are suffering in silence from some form of sexual health issue yet there is no need. BMG has a success rate of 98%, so a satisfying sex life is in the cards for those taking that first step.
Shaw said that many of the well-known erectile dysfunction medications only work for 50% of men and, in fact, can pose a danger for those with underlying cardiovascular issues. Veterans in need will receive initial complimentary medication.
There are new, safe, state-of-the-art treatments available for nearly all men that go beyond the well-known prescription meds, he said. There is hope for nearly all men and this free diagnostic test is the first step to seeking help.”
For more information or to schedule the free confidential diagnostic exam, visit http://www.BostonMedicalGroup.com or call 800-337-7555.
Diabetic Neuropathy Raises Risk of Erectile Dysfunction (ED), Urinary Problems
Men with type 1 diabetes with diabetic peripheral neuropathy (DPN) have an increased occurrence of erectile dysfunction and lower-urinary-tract symptoms, according to a new analysis of the Diabetes Control and Complications Trial/Epidemiology of …
Read more on Renal and Urology News
Free seminar on men's health at Taree
The seminar is being offered to educate men on prostate cancer and the possible problems post treatment such as erectile dysfunction and incontinence. The event will provide an opportunity for the community to learn, share their experiences and ask …
Read more on Manning River Times
OxyContin, Cialis makers avoid court in bid to win patent fights
LA Biomed said the drugmaker changed its prescription label after learning of the school's patented research that once-daily use of Cialis can treat scar tissue that may be the underlying cause of erectile dysfunction. The new marketing translated to a …
Read more on Chicago Tribune
Testosterone and Mortality
The European Male Aging Study (EMAS), involving 3369 men, defined late-onset hypogonadism as the presence of at least 3 sexual symptoms (loss of morning erections, low sexual desire and erectile dysfunction), total testosterone (TT) <320 ng/dl (11 nmol …
Read more on Medscape
What men should know about side effects of prostate cancer treatment
Most common long-term side effects of any treatment for prostate cancer are related to urinary issues, including incontinence (difficulty controlling urination), urgency and frequency, as well as sexual problems (erectile dysfunction). Can they be …
Read more on Baltimore Sun
Family of Virginia Man Files Wrongful Death Testosterone Lawsuit
This is a disorder in which a blood clot can become lodged in the deep veins of the body, usually in the lower legs or thighs. It is a dangerous … Symptoms may include infertility, erectile dysfunction, decrease in muscle mass, and loss of bone mass …
Read more on Legal Examiner
You can now get Basic Instinct Formula on Amazon Kindle Store for just .99. Search “Basic Instinct Formula” on amazon.
ALL THE METHODS of Treatment of Erectile Dysfunction in 2 minutes For separate video on each treatment of Erectile Dysfunction contact http://mydoctortells.c…
Should Prescription Drugs Become OTC? Two Experts Weigh In
In 2013, oxybutynin transdermal patches and triamcinolone acetonide nasal spray became OTC, followed by esomeprazole and fluticasone proprionate in 2014.1 FDA approval of Cialis (tadalafil) as OTC treatment for erectile dysfunction is currently being …
Read more on Monthly Prescribing Reference
Digital Tools Unveiled to Improve Doctor-Patient Interaction
For example, David Cerino, the company's CEO, explained that it might help a patient with prostate cancer evaluate the risk for erectile dysfunction or other adverse events against the increased longevity that a prostatectomy might provide. "At the …
Read more on Medscape
London, UK (PRWEB) June 19, 2014
Fine Treatment is pleased to share a new BPH treatment success story coming from Madrid, Spain. Charles O., 60, a user of Dr. Allens Device for Prostate Care, provided 2 feedback reports: the first one came after 3 months of using the device, and the second one was sent after the total treatment period of 6 months. In essence, the use of Dr. Allens Device has reduced enlarged prostate in size, gradually relieving the troubling BPH symptoms and markedly improving the quality of life.
On April 19, 2014, Fine Treatment received an email from Charles saying, Big thanks to Dr. Simon Allen for his wonderful device. I started to wear this device since January 14, 2014. Now, after 3 months, practically all the bad symptoms are gone. I only feel a little urgency to urinate. I enjoy my life again. I wish that all men would know about this device. Once more, thank you sir.
On June 10, 2014, Charles wrote, An ultrasound report, dated June 2, 2014, shows that the prostate size has become normal in comparison with the one from December 2013. It is really amazing. I sleep well all the night now, wakening up to urinate once or none.
Ill be happy to be interviewed by journalists and I can show them all my analyses and ultrasound report, adds Charles.
Fine Treatment works hard to disseminate treatment knowledge. Thermobalancing therapy is a superior treatment method enabled by Dr. Allens Devices. Fine Treatment does its best to make this natural treatment available internationally.
At the same time, recent articles in The Jewish Voice and Trinidad Express have reported issues with taking prostate medications, a common BPH treatment method which, however, is likely to cause nasty side effects.
The Jewish Voice article on Enlarged Prostate: What is it? What are the treatments? dated June 18, 2014, states: Alpha reductase inhibitors, Avodart or Proscar, reduce the size of the prostate, thus reducing the pressure on the urethra. Often, improvements are not seen for a couple of weeks or even months. Common side effects include decreased sex drive and erectile dysfunction.
Another article titled Doc, what to do about this BPH? in the Trinidad Express, of May 25, 2014, warns, It is important to note that one side effect of Alpha Blockers is they can lower your blood pressure causing dizziness that could lead to falls.
Fine Treatment is active in monitoring customer treatment progress. Here you can watch a short video: http://www.youtube.com/watch?v=V5xidswhxJM where a man has shrunk enlarged prostate by wearing Dr. Allens Device for 2 years without any medications.
Fine Treatments customer base stretches over 100 countries around the globe, notes Dr. Simon Allen. We do our best to help people to improve their health wherever they are. This new user report confirms the amazing effectiveness of therapeutic Dr. Allens Device and treatment method which cleanses the prostate gland and relieves nasty BPH symptoms naturally.
For details, visit Fine Treatment at http://finetreatment.com/bph-treatment-prostate-enlargement.
About Dr. Simon Allen and Fine Treatment:
Dr. Simon Allen, MD, PhD, Academician, member of the ATA, is a highly experienced medical professional. He specializes in internal medicine. He has treated a wide range of chronic diseases, including patients after a heart attack, with kidneys problems, including kidney stones disease, prostate and spine conditions, as well as metabolic disorders.
Fine Treatment supports global customer outreach, and ensures international availability of Dr. Allens Devices for the treatment of chronic prostatitis and BPH, coronary heart disease, for dissolving kidney stones, as well as for easing headaches, dizziness, and relieving lower back pain and sciatica.
Sex after prostate cancer
Despair is a common reaction, said Paul Nelson, a Hartford, Conn., teacher who became a clinical sexuality educator and founded the Erectile Dysfunction Foundation after surviving prostate cancer. "I tell them they're going to be OK, that they will …
Read more on Chicago Tribune
Vivus, Inc. Opens Sharply Higher On ED Drug Marketing Approval
The drug, avanafil, can be effective when taken as early as 15 minutes before sexual activity, the company said. The U.S. Food and Drug Administration cleared the drug for marketing in its first approval of an erectile dysfunction treatment in nearly …
Read more on Benzinga
Albany, NY (PRWEB) March 03, 2014
According to a new market report published by Transparency Market Research “Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) -Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the global erectile dysfunction drugs market was valued at USD 4.3 billion in 2012 and is expected to decline at a CAGR of (4.5%) from 2013 to 2019, to reach an estimated value of USD 3.4 billion in 2019.
Browse the full report with complete TOC at http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html
Erectile dysfunction is the inability to attain or maintain penile erection in men, sufficient for successful sexual intercourse. Erectile dysfunction is a common medical disorder primarily affecting men older than 40 years of age. In addition, other than the typical causes of erectile dysfunction, such as diabetes and hypertension, a number of common lifestyle related factors are also associated with development of the condition. These include obesity, excessive alcohol consumption, smoking, use of recreational drugs, and poor physical and psychological health. Commonly, oral drugs belonging to the PDE 5 inhibitors class form the mainstay of erectile dysfunction treatment. Other treatment options include lifestyle modification, testosterone therapy, penile devices, injection therapies and psychotherapy.
The global market for erectile dysfunction drugs has been studied from the perspective of currently marketed branded drugs and pipeline drugs. Branded drugs include Viagra (sildenafil citrate), Cialis (tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), MUSE (medicated urethral systems for erection), Mvix (mirodenafil) and Helleva (lodenafil). The drugs in the pipeline for erectile dysfunction treatment primarily consist of two major drugs, namely Vitaros (alprostadil) and Uprima (apomorphine) currently in later phases of clinical trials.
In 2012, Viagra (sildenafil citrate) accounted for the largest share (45%) by revenue of the total erectile dysfunction drugs market. However, due to the loss of the drug’s patent exclusivity in Europe and other countries in 2013, the overall market revenue is expected to decline during the forecast period as international markets contribute considerably to the overall market revenue of the drug. In the U.S. market, Viagra will continue to maintain a major revenue share due to its extended patent exclusivity till 2020. The market for Cialis (tadalafil) accounted for the second largest share at USD 1,926.8 million, in 2012. However, it is expected to witness a decline in market revenue at a CAGR of (12.6%) from 2013 to 2019, owing to loss of patent exclusivity in 2017. In addition, the patent for Bayer’s Levitra/Staxyn (vardenafil) is scheduled to expire in 2018 and is thus expected to contribute to the declining market revenue.
A few novel compounds are currently under investigation in both preclinical and clinical settings, for the treatment of impotency. These studies are majorly focused on medications with improved efficacy, shorter onset of action and fewer side effects as compared to the currently available treatments. Such pipeline drugs include Vitaros (alprostadil), Uprima (apomorphine) and Topiglan (alprostadil), amongst others.
Geographically, North America dominated the global market for erectile dysfunction drugs in terms of revenue generation and is expected to maintain its position throughout the forecast period. The extended patent exclusivity for Pfizer’s Viagra (sildenafil citrate) in the U.S., till 2020, will be responsible for the leadership of the North American market. Europe was the second largest regional market for erectile dysfunction drugs in 2012, owing to the increased demand for ED drugs. Market growth will also be facilitated by the expected marketing approvals for a few promising drug candidates such as Stendra/Spedra (avanafil) and Zydena (udenafil) by mid 2014.
Related Report: Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market
This report studies the global erectile dysfunction drugs market with a major focus on the branded drugs which include Viagra (sildenafil citrate), Cialis (tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil) and others such as MUSE (Medicated Urethral System for Erections), Mvix and Helleva. Pipeline analysis for drugs namely, Vitaros (alprostadil), Uprima (apomorphine) and few others have also been included in the report. Market size and forecasts for the period 2010 2019 have been provided for each of the drugs, in terms of USD million, considering historical data for 2010 and 2011, and base year as 2012. The % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 – 2019 has also been provided along with market size estimations.
Geographically, the market has been segmented into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). The respective market size and forecast till 2019 for each region has also been presented in the report along with the CAGR. In addition, the market overview section of the report provides a qualitative assessment of the market dynamics wherein the drivers, restraints, and opportunities along with market attractiveness and Porters Five Forces analysis have been studied.
Browse Blog: http://www.tmrblog.com/
Browse all Market Research reports: http://www.transparencymarketresearch.com
Belly lint, WiFi and hamsters on Viagra – inside the Ig Nobel prizes
Look down at your bellybutton – discreetly, if you're at work. Is there fluff or lint inside it? Yes? There's a very strong chance that it's blue. The reasons for this only became clear when Australian scientist, author and broadcaster Dr Karl …
Read more on ninemsn
Man jailed for peddling hyper-strength 'herbal' erection tablets
A man has been sentenced to 16 weeks in a UK prison for selling sham 'Herbal Viagra' tablets that contained dangerous levels of tadalafil and sibutramine, compounds that are banned in supplements.
Read more on NutraIngredients.com
Welch Allyn adds early warning scoring to Connex Vital Signs Monitor at no …
Aston Abbotts, UK – (HealthTech Wire / News) – Welch Allyn is now supporting the drive to improve patient safety and buy viagra lowest price reduce error rates with the addition of electronic Early Warning Score (EWS) functionality to its Connex® Vital …
Read more on HealthTech Wire